Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8(+) large granular lymphocyte leukemia

BACKGROUND: T-cell large granular lymphocytic leukemia is a clonal proliferation of cytotoxic T-lymphocytes which often results in severe cytopenia. Current treatment options favor chronic immunosuppression. Alemtuzumab, a humanized monoclonal antibody against glycophosphatidylinositol-anchored CD52...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Mohan, Sanjay R., Clemente, Michael J., Afable, Manuel, Cazzolli, Heather N., Bejanyan, Nelli, Wlodarski, Marcin W., Lichtin, Alan E., Maciejewski, Jaroslaw P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ferrata Storti Foundation 2009
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2754957/
https://ncbi.nlm.nih.gov/pubmed/19794084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.009191
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller